IMATINIB | IMATINIB | ATC L01XE01
ANTINEOPLASTIC AGENTS PROTEIN TYROSINE KINASE INHIBITORS TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) | ORAL | F 98 PERCENT VD 285 LITER (EQN) PPB 95 PERCENT Cl 11 LITER / HOUR HT 18 HOUR SOLUBILITY SOLUBLE IN AQUEOUS BUFFERS < PH 5.5 BUT IS VERY SLIGHTLY SOLUBLE TO INSOLUBLE IN NEUTRAL OR ALKALINE AQUEOUS BUFFERS | BCR-ABL TYROSINE KINASE PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGF) STEM CELL FACTOR (SCF) C-KIT PDB 3MSS (ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE) LIGAND CODE = STI (link to the list of PDB complexes) Download experimental 3D coordinates of STI with added hydrogens | TYROSINE-PROTEIN KINASE ABL INHIBITOR CHEMBL1862 TYROSINE-PROTEIN KINASE ABL P00519 TYROSINE-PROTEIN KINASE ABL1 HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TK ABL | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |